profit from every $100 of sales.
$0$100
Brookdale Senior Living
$8.96-2.82% today
-14.7% in 1 year
1-year low $8.961-year high $16.77
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Brookdale Senior Living sold, what it kept, and what it did with the cash.
Sales went from $2.74 billion in 2022 to $3.19 billion in 2025, with -$263 million of profit last year.
SalesProfit
Brookdale Senior Living vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Brookdale Senior Living | No profit yet | ||
 Tenet Healthcare | 16.2× · Fair price | ||
 Solventum | 9.7× · Cheap | ||
 Encompass Health | 24.4× · Fair price | ||
 Fresenius Medical Care AG & Co. KGaA | 10.4× · Cheap |
AI analysis
An AI analyst reads Brookdale Senior Living's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2,745 | 3,007 | 3,125 | 3,194 | |
| 514 | 738 | 799 | 838 | |
| -87 | 23 | 55 | 87 | |
| 320 | 402 | 413 | 344 | |
| -238 | -189 | -202 | -263 | |
| -1.25 | -0.84 | -0.89 | -1.12 | |
| 18.7% | 24.5% | 25.6% | 26.2% | |
| -3.2% | 0.8% | 1.8% | 2.7% | |
| -8.7% | -6.3% | -6.5% | -8.2% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 5,937 | 5,573 | 6,336 | 5,952 |
| Cash | 399 | 278 | 309 | 279 |
| Total debt | 4,893 | 4,726 | 5,652 | 5,516 |
| Total liabilities | 5,353 | 5,168 | 6,122 | 5,996 |
| 583 | 404 | 212 | -45 | |
| 190 | 225 | 228 | 235 | |
| -0.5% | 0.8% | 0.6% | -0.4% | |
| -40.9% | -46.8% | -95.0% | 587.0% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 3 | 163 | 166 | 218 | |
| 197 | 233 | 201 | 202 | |
| -194 | -70 | -35 | 17 | |
| Dividends paid | 0 | 0 | 0 | – |
| 0 | – | – | – | |
| 14 | 12 | 14 | 12 |
Valuation
- –
- –
- –
- -56.6×
- 0.7×
- 129.9×
- 21.5×
- 0.8%
- -12.3%
- 0.0%
Profitability
- 26.2%
- 2.7%
- -8.2%
- 12.5%
- 0.7%
- -3.4%
- 40,118.6%
- -3.5%
- 0.7%
- –
Growth
- +5.2%
- –
- −739.7%
- –
- +6.1%
Financial health
- 13.5×
- -98.59
- 93.5%
- 0.2×
- 3.44
- 3.44
- 0.53
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 37%of 952
Bottom 33%of 883
Bottom 27%of 870
Bottom 46%of 985
What analysts expect
- Average price target
- $17.67
- Range
- $17.00 – $18.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 6, 2026 | -0.03 | 0.03 | −200.0% |
| Feb 18, 2026 | -0.17 | -0.16 | −6.3% |
| Nov 6, 2025 | -0.20 | -0.16 | −25.0% |
| Aug 6, 2025 | -0.18 | -0.14 | −28.6% |
| May 6, 2025 | -0.11 | -0.11 | +0.0% |
| Feb 18, 2025 | -0.37 | -0.16 | −131.3% |
| Nov 7, 2024 | -0.22 | -0.17 | −29.4% |
| Aug 8, 2024 | -0.17 | -0.13 | −30.8% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
18No pass
Benjamin Graham
43No pass
Philip Fisher
21No pass
Peter Lynch
12No pass
Joel Greenblatt
0No pass
Charlie Munger
29No pass
Terry Smith
38No pass
Questions about Brookdale Senior Living
Is Brookdale Senior Living a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Brookdale Senior Living AI analysis
What does Brookdale Senior Living do?
Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). It is in Medical - Care Facilities, based in Brentwood, TN, United States, with 22,440 employees.
Does Brookdale Senior Living pay a dividend?
No. Brookdale Senior Living does not pay a dividend at the moment.
Is Brookdale Senior Living stock halal?
No. Brookdale Senior Living does not pass our halal screen: its debt is 257% of its market value, at or above the 33% limit. How we check
How has Brookdale Senior Living stock done over the past year?
Down 14.7% over the past twelve months, to $8.96. It traded between $8.96 and $16.77 and is 46.6% below its high.
Who are Brookdale Senior Living's competitors?
The largest listed companies in the same industry are Tenet Healthcare, Solventum, Encompass Health and Fresenius Medical Care AG & Co. KGaA. The peers table on this page compares their profit, growth and price with Brookdale Senior Living's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.